Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,100.00
0.00 (0.00%)
At close: Dec 30, 2025
146.42%
Market Cap28.75B
Revenue (ttm)1.00B
Net Income (ttm)-13.37B
Shares Out9.28M
EPS (ttm)-1,637.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,327
Average Volume19,603
Open3,100.00
Previous Close3,100.00
Day's Range3,095.00 - 3,300.00
52-Week Range680.00 - 3,300.00
Beta-0.07
RSI79.56
Earnings Daten/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy. The company was founded in 2015 and is based in Seongnam, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.